Evidence map›Paper›PMID 28667327›Full record

ArticleScientific reports2017

Intermolecular steric inhibition of Ephexin4 is relieved by Elmo1.

Kwanhyeong Kim, Juyeon Lee, Sang-Ah Lee, Hyunji Moon, Boyeon Park, Deokhwan Kim, Young-Eun Joo, Daeho Park

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Double inhibition and activation mechanisms of Ephexin family RhoGEFs.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kwanhyeong KimSchool of Life Sciences and Aging Research Institute, Gwangju Institute of Science and Technology, Gwangju, 61005, Korea.
Juyeon LeeSchool of Life Sciences and Aging Research Institute, Gwangju Institute of Science and Technology, Gwangju, 61005, Korea.
Sang-Ah LeeSchool of Life Sciences and Aging Research Institute, Gwangju Institute of Science and Technology, Gwangju, 61005, Korea.
Hyunji MoonSchool of Life Sciences and Aging Research Institute, Gwangju Institute of Science and Technology, Gwangju, 61005, Korea.
Boyeon ParkSchool of Life Sciences and Aging Research Institute, Gwangju Institute of Science and Technology, Gwangju, 61005, Korea.
Deokhwan KimSchool of Life Sciences and Aging Research Institute, Gwangju Institute of Science and Technology, Gwangju, 61005, Korea.
Young-Eun JooDepartment of Internal Medicine, Chonnam National University Medical School, Gwangju, 61469, Korea.
Daeho ParkSchool of Life Sciences and Aging Research Institute, Gwangju Institute of Science and Technology, Gwangju, 61005, Korea. daehopark@gist.ac.kr.
Gwangju Institute of Science and Technology · KREwha Womans University · KRChonnam National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ephexin4, a guanine nucleotide-exchange factor for RhoG, promotes engulfment of apoptotic cells and cancer cell migration in a RhoG-dependent manner, which is synergistically augmented by Elmo1, an Ephexin4-interacting protein. However, the underlying molecular mechanism remains elusive. Here, we report a mechanism by which Elmo1 cooperates with Ephexin4 to activate RhoG. We found that Ephexin4 activity was increased by elimination of its SH3 domain which intermolecularly interacts with the N20 region of Ephexin4. This interaction prevented RhoG from binding to Ephexin4 and thus inhibited RhoG activation. Moreover, we also found that Elmo1 associated with the SH3 domain as well as the N20 region and competed with the SH3 domain for binding to the N20 region, interrupting the interaction of the SH3 domain with the N20 region and thereby promoting RhoG binding to Ephexin4. In addition, the activity of Ephexin4 lacking the SH3 domain was comparable to that of Ephexin4 with Elmo1. Taken together, the data suggest that Elmo1 relieves the steric hindrance of Ephexin4 generated by the intermolecular interaction of the SH3 domain and makes Ephexin4 more accessible to RhoG.

Indexed as

Adaptor Proteins, Signal TransducingCell LineGuanine Nucleotide Exchange FactorsHumansModels, BiologicalProtein BindingProtein Interaction Domains and Motifsrho GTP-Binding Proteinssrc Homology DomainsAdaptor Proteins, Signal TransducingARHGEF16 protein, humanELMO1 protein, humanGuanine Nucleotide Exchange FactorsRHOG protein, humanrho GTP-Binding Proteins

Identifiers

PMID28667327
PMCPMC5493634
OpenAlexW2723881072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.